- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aurobindo Pharma Limited — Updates, 07-04-2026: Press Release
07-04-2026 | 06:18 pm
07-04-2026 | 06:18 pm
Aurobindo Pharma secures USFDA approval for its diabetes drug, Dapagliflozin and Metformin. Targeting a US$ 51.4 Cr market, the product launches immediately with 180-day generic exclusivity.
No comments yet. Be the first to comment!